当前位置:首页 - 行情中心 - 仁和药业(000650) - 财务分析 - 现金流量表

仁和药业

(000650)

  

流通市值:71.63亿  总市值:75.32亿
流通股本:13.31亿   总股本:14.00亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金893,568,477.914,231,975,509.283,183,899,963.582,239,324,883.79
  收到的税费返还1,633.95-9,566.879,566.87
  收到其他与经营活动有关的现金11,674,394.66114,386,672.14152,493,969.37113,614,112.34
  经营活动现金流入小计905,244,506.524,346,362,181.423,336,403,499.822,352,948,563
  购买商品、接受劳务支付的现金530,025,908.332,461,083,405.581,641,990,931.591,085,631,515.73
  支付给职工以及为职工支付的现金160,636,569.49497,902,079.93373,423,486.14274,687,525.18
  支付的各项税费43,659,264.25354,244,479.95236,942,118.38174,511,732.47
  支付其他与经营活动有关的现金46,369,106.83181,820,216.06243,562,700.58146,677,896.16
  经营活动现金流出小计780,690,848.93,495,050,181.522,495,919,236.691,681,508,669.54
  经营活动产生的现金流量净额124,553,657.62851,311,999.9840,484,263.13671,439,893.46
二、投资活动产生的现金流量:
  收回投资收到的现金2,849,258,339.0711,834,967,400.686,501,596,227.454,600,560,979.11
  取得投资收益收到的现金19,078,949.78114,414,815.2159,326,090.0340,140,512.14
  处置固定资产、无形资产和其他长期资产收回的现金净额5,750360,236.15220,071.8532,234.79
  投资活动现金流入小计2,868,343,038.8511,949,742,452.046,561,142,389.334,640,733,726.04
  购建固定资产、无形资产和其他长期资产支付的现金18,641,157.8674,587,219.1356,124,503.1242,411,635.49
  投资支付的现金4,737,531,289.4511,973,376,888.598,357,743,246.236,451,769,798.85
  取得子公司及其他营业单位支付的现金-63,489.2695,461.923,169.71
  投资活动现金流出小计4,756,172,447.3112,048,027,596.988,413,963,211.256,494,204,604.05
  投资活动产生的现金流量净额-1,887,829,408.46-98,285,144.94-1,852,820,821.92-1,853,470,878.01
三、筹资活动产生的现金流量:
  吸收投资收到的现金080,00080,00080,000
  其中:子公司吸收少数股东投资收到的现金080,00080,00080,000
  取得借款收到的现金0---
  收到其他与筹资活动有关的现金02,325,000-0
  筹资活动现金流入小计02,405,00080,00080,000
  偿还债务支付的现金0---
  分配股利、利润或偿付利息支付的现金0306,106,206.24238,342,279.2211,818,640.33
  其中:子公司支付给少数股东的股利、利润095,623,262.8428,351,544.12,160,774.19
  支付其他与筹资活动有关的现金0918,992.42-0
  筹资活动现金流出小计0307,025,198.66238,342,279.2211,818,640.33
  筹资活动产生的现金流量净额0-304,620,198.66-238,262,279.2-211,738,640.33
四、汇率变动对现金及现金等价物的影响-20,777.29-9,950.5--
五、现金及现金等价物净增加额-1,763,296,528.13448,396,705.8-1,250,598,837.99-1,393,769,624.88
  加:期初现金及现金等价物余额2,773,961,378.542,325,564,672.742,325,564,672.742,325,564,672.74
  期末现金及现金等价物余额1,010,664,850.412,773,961,378.541,074,965,834.75931,795,047.86
补充资料:
  净利润-487,656,749.45-355,240,856.89
  资产减值准备-129,175,268.45--99,651.05
  固定资产和投资性房地产折旧-100,603,259.87-49,866,986.19
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-100,603,259.87-49,866,986.19
  无形资产摊销-14,615,618.05-7,251,544.98
  长期待摊费用摊销-3,372,841.37-1,811,477.82
  处置固定资产、无形资产和其他长期资产的损失--2,048,182.02--2,000,511.4
  固定资产报废损失-407,460.75-149,572.46
  公允价值变动损失--25,116,621.86--39,303.94
  财务费用-90,869.76-43,293.13
  投资损失--83,430,024.12--26,729,093.05
  递延所得税-306,297.07-2,389,711.5
  其中:递延所得税资产减少-410,567.3-2,419,071.41
    递延所得税负债增加--104,270.23--29,359.91
  存货的减少--49,230,030.81-121,785,151.43
  经营性应收项目的减少-178,959,085.45--19,579,650.04
  经营性应付项目的增加-78,307,579.87-164,308,462.55
  其他--15,529,062.5-8,134,270.8
  现金的期末余额-2,773,961,378.54-931,795,047.86
  减:现金的期初余额-2,325,564,672.74-2,325,564,672.74
  现金及现金等价物的净增加额-448,396,705.8--1,393,769,624.88
公告日期2026-04-282026-04-242025-10-312025-08-26
审计意见(境内)标准无保留意见
TOP↑